摘要
目的:比较微创以及开放手术治疗症状性子宫肌瘤对近远期疗效的影响,评价微创技术的应用价值。方法:选取2013年2月-2015年6月医院妇科采用开腹手术子宫肌瘤92例纳入传统组,同期医院采用微创术式治疗的子宫肌瘤患者125例纳入微创组。比较两组患者的手术时间、术中出血量、术后卧床时间、术后恢复进食时间、月经恢复时间、并发症、肌瘤残留、症状控制、复发率。结果:微创组手术时间高于传统组,术中出血量、术后卧床时间、术后恢复进食时间、月经恢复时间、并发症合计发生率低于传统组,两组比较差异均有统计学意义(P<0.05)。两组肌瘤残留、症状控制、复发率比较差异均无统计学意义(P>0.05)。结论:微创手术并不能提高肌瘤剔除、症状控制、预防复发效果,但可减轻创伤,加速患者康复。
Objective： To evaluate the efficacy of minimally invasive and open surgery in the treatment of symptomatic uterine fibroids and evaluate the value of minimally invasive technique in the treatment of symptomatic uterine fibroids.Method： From February 2013 to June 2015, the 92 cases of uterine fibroids were treated with open surgery, and 125 patients with uterine myoma were treated by minimally invasive surgery.The operation time, blood volume, postoperative bed time, postoperative recovery time, menstrual recovery time, complications of total incidence, residual myoma, symptom control, and recurrence rate of two groups were compared.Result： The operation time of minimally invasive group was higher than that of the traditional group, blood volume, postoperative bed time, postoperative recovery time, menstrual recovery time, and complications of total incidence in minimally invasive group were lower than those in the traditional group, the differences were statistically significant （ P〈0.05 ） . The difference of residual myoma, symptom control, and recurrence rate of two groups were not statistically significant （P〉0.05） .Conclusion： Minimally invasive surgery can not improve the effect of myoma rejection, symptom control, or prevention of recurrence, but can reduce the trauma, accelerate the rehabilitation of patients.
出处
《中国医学创新》
CAS
2017年第4期127-129,共3页
Medical Innovation of China
关键词
微创
子宫肌瘤
临床意义
Minimally invasive
Uterine fibroids
Clinical significance
